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Abstract
The neuropeptide BW receptor 1 (NPBW1, provisional nomenclature [5]) is activated by two 23-amino-acid
peptides, neuropeptide W (neuropeptide W-23) and neuropeptide B (neuropeptide B-23) [20, 6]. C-terminally
extended forms of the peptides (neuropeptide W-30 and neuropeptide B-29) also activate NPBW1 [2]. Unique to
both forms of neuropeptide B is the N-terminal bromination of the first tryptophan residue, and it is from this post-
translational modification that the nomenclature NPB is derived. These peptides were first identified from bovine
hypothalamus and therefore are classed as neuropeptides. Endogenous variants of the peptides without the N-
terminal bromination, des-Br-neuropeptide B-23 and des-Br-neuropeptide B-29, were not found to be major
components of bovine hypothalamic tissue extracts. The NPBW2 receptor is activated by the short and C-
terminal extended forms of neuropeptide W and neuropeptide B [2].
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